ArticleMovement disorders : official journal of the Movement Disorder Society2017
Incidence and time trends of drug-induced parkinsonism: A 30-year population-based study.
Article in Movement disorders : official journal of the Movement Disorder Society, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers, 2 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
42 citing papers in PubMed, 2 syntheses or guidelines pooled it, 102 citations in OpenAlex.
- Case Definitions and Data Sources for NNCSS Parkinson Disease Surveillance: A Systematic Review.JAMA network open · 2026Pooled it
- Association Between β-Adrenoreceptor Agonists and Antagonists and Parkinson's Disease: Systematic Review and Meta-Analysis.Pharmacoepidemiology and drug safety · 2025Pooled it
- Comparative Analysis of the Incidence, Prevalence, and Survival of 8 Types of Parkinsonism in a Population-Based Study with 367 Million Person Years of Observation over 21 Years.Movement disorders clinical practice · 2026Observational
- Mild motor signs and depression: more than just medication side effects?European archives of psychiatry and clinical neuroscience · 2026Article
- Cumulative incidence and risk factors of dementia in Parkinson's disease and parkinsonism: a population-based study.Brain communications · 2026Article
- Drug-Induced Parkinsonism: A Structured, Mechanism-Informed Approach to Identification and Management.Cureus · 2025Review
- Unmasking the hidden culprit: neurosyphilis mimicking parkinsonism in a middle-aged male.BMC neurology · 2025Article
- Exploring cognitive and emotional symptoms associated with hippocampal subfield atrophy in drug-induced Parkinsonism.Frontiers in aging neuroscience · 2025Article
- Review
- Subcortical structure alteration in patients with drug-induced parkinsonism: Evidence from neuroimaging.IBRO neuroscience reports · 2024Article
- Prevalence and causative drugs of drug-induced Parkinsonism in pediatric patients.European child & adolescent psychiatry · 2023Article
- Adequate diagnosis of the cause of Parkinsonism and treatment in an elderly patient with schizophrenia: A case report.PCN reports : psychiatry and clinical neurosciences · 2023Article
- Risk factors, clinical correlates, and social functions of Chinese schizophrenia patients with drug-induced parkinsonism: A cross-sectional analysis of a multicenter, observational, real-world, prospective cohort study.Frontiers in pharmacology · 2023Article
- Article
- Probable progressive supranuclear palsy in a patient with chronic schizophrenia: A case report.Experimental and therapeutic medicine · 2022Article
- Use of antipsychotics and long-term risk of parkinsonism.Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology · 2022Article
- Respecting the Patient's Choice: A Case of Possible Drug-Induced Parkinsonism.Pharmacy (Basel, Switzerland) · 2022Article
- Prospective Five-Year Follow-Up of Patients with Schizophrenia Suspected with Parkinson's Disease.Parkinson's disease · 2022Article
- The potential role of the cardiac MIBG scan in differentiating the drug-induced Parkinsonism from Parkinson's disease.Clinical parkinsonism & related disorders · 2022Article
- Differences in cause and 12-month follow-up outcome of parkinsonian symptoms in depressed older adults treated with antipsychotics: a case series.BMC psychiatry · 2021Article
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
6 authors at 2 institutions in 1 country.
Funding
Abstract
backgroundEpidemiological studies of drug-induced parkinsonism remain limited.
objectivesTo investigate the incidence and time trends of drug-induced parkinsonism over 30 years in a geographically defined American population.
methodsWe used the medical records-linkage system of the Rochester Epidemiology Project to identify all persons in Olmsted County, Minnesota, who received a screening diagnostic code for parkinsonism from 1976 through 2005. A movement disorders specialist reviewed the complete medical records of each person to confirm the presence of drug-induced parkinsonism associated with dopamine-blocking or dopamine-depleting medications.
resultsAmong 906 incident cases of parkinsonism from 1976 to 2005, 108 persons had drug-induced parkinsonism (11.9%). The average annual incidence rate of drug-induced parkinsonism was 3.3 per 100,000 person-years, was higher in women, and increased with older age. Drug-induced parkinsonism was the fifth-most common type of parkinsonism overall; however, it was the most common type among persons younger than age 40 years. Typical antipsychotic drugs were the most common class of drugs associated with parkinsonism, whereas atypical antipsychotic drugs were rarely involved. The incidence rate of drug-induced parkinsonism decreased 32.0% per decade (relative risk = 0.68; 95% confidence interval: 0.49-0.94) and 68.6% over the 30 years of the study. The decrease was similar in men (65.2%) and women (69.4%); however, the trend was significant only in women.
conclusionsThe incidence of drug-induced parkinsonism increased with older age and was higher in women at all ages. Typical antipsychotic drugs were the most common cause. The incidence of drug-induced parkinsonism decreased over the 30 years of the study because of changes in drug use. © 2016 The Authors. Movement Disorders published by Wiley Periodicals, Inc. on behalf of International Parkinson and Movement Disorder Society.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.